COVID-19 Updates

Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020

Foldax was named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the…
Biden Supports IP Waiver for COVID-19 Vaccines

The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual…
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd)…
U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function…
Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues

Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology…
UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership…
PhotoPharmics Innovations Address Global Health Inequalities

PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’…
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from…
Innovative Med Tech Startup Xenter Announces Company Launch

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur…
Utah’s Recursion Goes Public – Announces Pricing of IPO

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock…
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee.…
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test…